Genscript Biotech (01548) Announces Monthly Return on Securities for November 2025

Bulletin Express12-02

Genscript Biotech Corporation (Stock Code: 01548) published the monthly return on movements in securities for the month ended 30 November 2025. The authorized share capital remained at USD 5,000,000, with no change in the total of 5,000,000,000 authorized shares.

The number of issued shares increased from 2,185,678,939 to 2,186,218,520, representing a net rise of 539,581 shares. Among these, 50,000 new shares were issued under the post-IPO share option scheme, raising HKD 350,740 in total. Another 489,581 new shares were issued in respect of share awards at a price of HKD 0.00778 per share. No changes occurred in treasury shares, warrants, convertible securities, or other issuance arrangements during the reporting period.

The information was submitted on 02 December 2025 by a director of Genscript Biotech Corporation and reflects compliance with relevant Hong Kong Stock Exchange requirements.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1105023170?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-12-02 16:46","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1105023170","market":"us","top_or_hot":-1,"title":"Genscript Biotech (01548) Announces Monthly Return on Securities for November 2025","media":"Bulletin Express","content":"<p>Genscript Biotech Corporation (Stock Code: 01548) published the monthly return on movements in securities for the month ended 30 November 2025. The authorized share capital remained at USD 5,000,000, with no change in the total of 5,000,000,000 authorized shares.</p>\n<p>The number of issued shares increased from 2,185,678,939 to 2,186,218,520, representing a net rise of 539,581 shares. Among these, 50,000 new shares were issued under the post-IPO share option scheme, raising HKD 350,740 in total. Another 489,581 new shares were issued in respect of share awards at a price of HKD 0.00778 per share. No changes occurred in treasury shares, warrants, convertible securities, or other issuance arrangements during the reporting period.</p>\n<p>The information was submitted on 02 December 2025 by a director of Genscript Biotech Corporation and reflects compliance with relevant Hong Kong Stock Exchange requirements.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Genscript Biotech (01548) Announces Monthly Return on Securities for November 2025</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGenscript Biotech (01548) Announces Monthly Return on Securities for November 2025\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2025-12-02 16:46</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Genscript Biotech Corporation (Stock Code: 01548) published the monthly return on movements in securities for the month ended 30 November 2025. The authorized share capital remained at USD 5,000,000, with no change in the total of 5,000,000,000 authorized shares.</p>\n<p>The number of issued shares increased from 2,185,678,939 to 2,186,218,520, representing a net rise of 539,581 shares. Among these, 50,000 new shares were issued under the post-IPO share option scheme, raising HKD 350,740 in total. Another 489,581 new shares were issued in respect of share awards at a price of HKD 0.00778 per share. No changes occurred in treasury shares, warrants, convertible securities, or other issuance arrangements during the reporting period.</p>\n<p>The information was submitted on 02 December 2025 by a director of Genscript Biotech Corporation and reflects compliance with relevant Hong Kong Stock Exchange requirements.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01548","symbol_name":"金斯瑞生物科技","start_time":0,"source_url":"","article_id":"1105023170","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1105023170","pubTimestamp":1764665169,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Genscript Biotech Corporation (Stock Code: 01548) published the monthly return on movements in securities for the month ended 30 November 2025. The authorized share capital remained at USD 5,000,000,...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01548":"金斯瑞生物科技"},"translate_title":"金斯瑞生物(01548)公布2025年11月证券月报表","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01548":1},"content_text":"Genscript Biotech Corporation (Stock Code: 01548) published the monthly return on movements in securities for the month ended 30 November 2025. The authorized share capital remained at USD 5,000,000, with no change in the total of 5,000,000,000 authorized shares.\nThe number of issued shares increased from 2,185,678,939 to 2,186,218,520, representing a net rise of 539,581 shares. Among these, 50,000 new shares were issued under the post-IPO share option scheme, raising HKD 350,740 in total. Another 489,581 new shares were issued in respect of share awards at a price of HKD 0.00778 per share. No changes occurred in treasury shares, warrants, convertible securities, or other issuance arrangements during the reporting period.\nThe information was submitted on 02 December 2025 by a director of Genscript Biotech Corporation and reflects compliance with relevant Hong Kong Stock Exchange requirements.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1105023170","isCrawlerRequest":true}